Company Filing History:
Years Active: 2020-2022
Title: Meaghan Hancock: Innovator in Cytomegalovirus Research
Introduction
Meaghan Hancock is a prominent inventor based in Aloha, Oregon, who has made significant contributions to the field of virology through her innovative research on cytomegalovirus (CMV). With a total of three patents to her name, her work primarily focuses on developing novel vectors aimed at eliciting immune responses against CMV.
Latest Patents
Hancock's latest patents showcase her groundbreaking approach to harnessing CMV vectors. One of her notable inventions is the patent titled "Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules." This patent details CMV vectors with key deletions that enhance selective CD8+ T cell responses. Specifically, the vectors lack active UL128, UL130, UL146, and UL147 proteins, creating an opportunity for more targeted immune activation.
Another significant patent by Hancock includes "CMV vectors comprising microRNA recognition elements," which describes recombinant CMV vectors engineered to include heterologous antigens. These vectors are designed to silence specific CMV gene expressions in the presence of myeloid cell-derived microRNAs. This technology sets the stage for generating unconventional immune responses, particularly emphasizing CD8+ T cell activation predominantly restricted by MHC-II.
Career Highlights
Meaghan Hancock is affiliated with Oregon Health & Science University, where she conducts her research. Her innovative contributions have not only advanced the understanding of CMV but have also paved the way for potential therapeutic applications in immunology and vaccine development. Through her patents, she demonstrates a commitment to leveraging technology for improved health outcomes.
Collaborations
Hancock collaborates closely with esteemed colleagues, including Jay A. Nelson and Scott G. Hansen. These collaborative efforts underscore the importance of teamwork in driving groundbreaking research and advancing scientific knowledge in the field of virology.
Conclusion
Meaghan Hancock stands out as an inventive force in the realm of cytomegalovirus research. Her patents reflect her dedication to improving immune response strategies and highlight the significant impact that innovative research can have on public health. As she continues her work at Oregon Health & Science University, Hancock's contributions will undeniably influence future developments in immunotherapy and infectious disease management.